Speaker

Alan Cash

CEO, METVITAL, INC.
San Diego, California, United States
Alan Cash
San Diego, CA

Education
University of Oklahoma
Masters Degree in Physics

University of Maine
Bachelor of Arts, Physics and Geology

Issued Patents
10,016,385 USA Method Patent Oxaloacetate compounds for Cancer
9,561,199 USA Composition of Matter Anhydrous Enol-Oxaloacetate
9,050,306 USA Method Patent for Oxaloacetate Stability
1824470 EPO Method Patent Oxaloacetate compounds for Cancer
CA 2,911,468 Canada Method Patent Oxaloacetate compounds for Alzheimer’s and Parkinson’s Disease
CA 2,589,995 Canada Method Patent Oxaloacetate compounds for Cancer
269485 India Method Patent Oxaloacetate compounds for cancer
JP, 5787911.B Japan Method Patent Oxaloacetate compounds for Weight Loss
JP, 5268362 Japan Method Patent Oxaloacetate compounds for Extending Lifespan
2005316295 Australia Method Patent Oxaloacetate for Lifespan, Cancer, Parkinson's
US FDA Orphan Drug Designations for Glial Tumors, Glioblastoma, Amyotrophic Lateral Sclerosis, Hepatocellular Carcinoma

Publications
Speaking In
2:15 PM - 2:30 PM
Wednesday, October 23
MetVital is a clinical-stage, metabolic therapy company developing first-in-class, broadly…